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Owing to the demand for low sample consumption and automated sample
changing capabilities at synchrotron small-angle X-ray (solution) scattering
(SAXS) beamlines, X-ray microfluidics is receiving continuously increasing
attention. Here, a remote-controlled microfluidic device is presented for
simultaneous SAXS and ultraviolet absorption measurements during protein
dialysis, integrated directly on a SAXS beamline. Microfluidic dialysis can be
used for monitoring structural changes in response to buffer exchange or, as
demonstrated, protein concentration. By collecting X-ray data during the
concentration procedure, the risk of inducing protein aggregation due to
excessive concentration and storage is eliminated, resulting in reduced sample
consumption and improved data quality. The proof of concept demonstrates the
effect of halted or continuous flow in the microfluidic device. No sample
aggregation was induced by the concentration process at the levels achieved in
these experiments. Simulations of fluid dynamics and transport properties within
the device strongly suggest that aggregates, and possibly even higher-order
oligomers, are preferentially retained by the device, resulting in incidental
sample purification. Hence, this versatile microfluidic device enables investiga-
tion of experimentally induced structural changes under dynamically control-
lable sample conditions.
1. Introduction
Small-angle X-ray scattering (SAXS), an increasingly popular
technique for obtaining low-resolution structural information
on biomacromolecules in solution, profoundly complements
other techniques for structural analysis of biomacromolecules,
such as crystallography and nuclear magnetic resonance. The
versatile sample handling often makes SAXS the tool of
choice for analyzing the structural changes of proteins in
response to variations in their experimental environment.
The constant demand for lower sample consumption and
more advanced ‘on-the-fly’ sample processing immediately
before or during an X-ray exposure makes microfluidics a
valuable future tool at SAXS beamlines. Microfluidic devices,
with their modular nature, offer advanced liquid sample
handling and the potential for a high level of integration of
common laboratory functions. These chips are also known as
lab-on-a-chip devices. Several successful microfluidic setups
on SAXS stations have been presented in the literature,
mostly focusing on mixing and/or high-throughput sample
delivery (Pollack et al., 1999; Akiyama et al., 2002; Uzawa et
al., 2004; Otten et al., 2005; Marmiroli et al., 2010; Toft et al.,
2008).
The potentially wide variety of experimental conditions that
may promote structural changes in a given protein solution are
often unknown prior to the experiment. Thus, it is a requisite
to analyze the structural state of a given protein under a large
number of experimental conditions (Toft et al., 2008; Lafleur et
al., 2011). Conventional biological SAXS experiments also
require exposure at multiple protein concentrations. It is good
practice to collect data at a minimum of three different
concentrations to ensure the absence of interparticle inter-
ference and concentration-dependent oligomerization in the
scattering data [for general guidelines, see e.g. Jacques et al.
(2012)]. Protein samples are hence typically concentrated
prior to data collection and data from a dilution series are
recommended.
An automated lab-on-a-chip microfluidic sample prepara-
tion system for SAXS has recently been presented (Toft et al.,
2008; Nielsen, 2009; Lafleur et al., 2011). This chip enabled
automated mixing of samples and featured a sample X-ray
chamber with fiber optics for integrated ultraviolet (UV)
measurements. The structural space of a therapeutically rele-
vant cytosolic signaling protein was successfully explored
using the mixing chip (Møller et al., 2013). In both experi-
ments, it was evident that several factors, including protein
concentration, influence the oligomeric state of the biomacro-
molecules, in either a reversible or an irreversible fashion.
Additionally, the requirement of high starting concentration
of the protein solution can promote protein aggregation and
may trap the protein in irreversible and often biologically
nonrelevant conformations. Thus, it is desirable to conduct
SAXS experiments from initially low concentrations and to
increase the concentration gradually while monitoring
potential structural changes.
Several groups have presented microfluidic devices for the
concentration of solutions. Khandurina et al. (2000) demon-
strated the use of a porous silicate membrane, allowing the
diffusion of water molecules between liquid phases with high
and low water activity, respectively. However, inconsistencies
with the on-chip concentration performance were also
reported. Wang et al. (2005) used a nanofluidic filter combined
with electrokinetic trapping to achieve a millionfold concen-
tration in protein solutions. Fabrication of this device involved
forming micro- and nanochannels in the same device. Kim &
Han (2008) have presented a microfluidic device in poly-
dimethylsiloxane (PDMS) with self-sealed nanoporous junc-
tions inside PDMS for concentration of protein solutions
applying an electric field over the nanoporous junction.
Charged molecules are translated along the electric field,
thereby enabling a concentration of proteins at pH values
differing from the theoretical pI. Kondapalli et al. (2011)
presented a microfluidic device that by similar principles
enables concentration of protein solutions via electric field
flow over a polyacrylamide membrane that at the same time
functions as an immune biosensor. These methods all include
either advanced fabrication for the membrane part or the
application of electric field flow. Kim et al. (2007) have a more
straightforward approach to fabrication of a microfluidic
device for protein solution concentration. By the use of a
conventional dialysis membrane sandwiched between two
PDMS sheets with microchannels, concentration of protein
solutions using simple membrane diffusion was demonstrated.
Here, we present a microfluidic device that enables
concentration screening of a given protein solution, following
the basic principles described earlier in the literature (Kim et
al., 2007). Importantly, the concentration device presented
here is integrated with a SAXS data collection sample cell and
the ability to monitor the UV signal of the concentrated
sample. Thereby, the device allows monitoring of potential
concentration-induced structural changes and/or aggregation.
This combined microfluidic device facilitates concentration
series or buffer exchange series on any SAXS beamline. The
combination of the microfluidic device with automation of the
coordinated fluidic control and beamline control and partially
automated data-processing software enables the user to make
‘on-the-fly’ adjustments to the experimental conditions
directly based on the observed data. This provides SAXS
beamline users with an unprecedented flexibility for optimized
data collection from a protein while concentrating the solu-
tion. As data can be automatically collected during the time it
takes for the concentration to reach a steady state, this
microfluidic device facilitates measurements with extremely
fine incremental steps of concentration that would otherwise
be very impractical to obtain by hand.
Field-flow fractionation (FFF) is an ultrafiltration-based
separation technique that shares important features with the
method discussed here (Fraunhofer & Winter, 2004). The
application of pressure to one side of a membrane can reverse
the normal diffusive flow and result in ultrafiltration (reverse
osmosis in the case of salts). The asymmetrical flow variant
(AF4) of the method utilizes a single membrane on one side of
a wide (>1 cm) sample-flow channel, but the technique is
typically optimized for separation rather than concentration
(Williams, 2012). Nonetheless, the fact that flow near a
membrane surface can separate species with varying diffusion
rates has important implications for the method we discuss.
2. Materials and methods
2.1. Fabrication
The microfluidic dialysis design includes two separate
modules: a dialysis chip where the actual dialysis occurs, and
an exposure chip where UVabsorption at 280 nm is monitored
and a SAXS exposure cell is located. The modular design
principle is implemented to allow modifications in one module
(e.g. inclusion of longer or wider dialysis channels) without
modification of the other module. The design of both chips is
illustrated in Fig. 1. Both chips were cast in PDMS from molds
created by micromilling into a polydimethyl methacrylate
(PMMA) substrate. The dialysis chip can be produced at very
low cost and is intended as a disposable device, meaning that a
new chip is recommended if the user changes between
different proteins to avoid contamination.
The dialysis chip consists of two sheets of PDMS (Fig. 1a),
one with 223 mm-long, 1 mm-wide and 0.12 mm-deep chan-
nels [the channel for the polyethylene glycol (PEG) solution],
and a second with identical channel design but with a depth of
0.05 mm (the channel for the protein solution). These
dimensions were chosen on the basis of earlier studies of
microfluidic dialysis chips (Kim et al., 2007) and the limitations
of the available micromilling fabrication method. A regener-
ated cellulose dialysis membrane (SpectraPor 3, 3.5 kDa
cutoff, Spectrum Laboratories Inc., Rancho Dominguez, CA,
USA) is sandwiched in-between the two PDMS sheets and
clamped together using two pieces of 5 mm-thick PMMA
plate.
The exposure chip has a thickness of 1 mm, which provides
an X-ray pathlength for the exposure channel (see Fig. 1b) at
an X-ray energy of 10 keV. Polystyrene (PS) of 25 mm thick-
ness was used as window material for the SAXS exposure cell
(ST311025 biaxially oriented, Goodfellow Corporation,
Coraopolos, PA, USA). PS is easy to work with and has been
shown to produce low scattering levels at small angles (Toft et
al., 2008; Gillilan et al., 2013). The windows were clamped to
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each side of the exposure chip over the exposure channel
using PMMA plates. The soft PDMS provides a good seal
around the windows and prevents leaks. This exposure cell
design facilitated manual removal of concentrated solution in
the cell by simply removing the sample from the exposure cell
outlet using a pipette. This is useful either for cleaning out the
previous sample or for external confirmation of the concen-
tration using a UV spectrometer (NanoVue, GE Healthcare
Biosciences, Pittsburgh, PA, USA).
2.2. Fluidic control setup
The dialysis chip and the exposure chip were connected
with short tubing (10 cm) with an inner diameter of 0.1 mm.
The PEG and protein solutions were introduced into the
dialysis chip using glass syringes (Hamilton) mounted in
remote-controlled syringe pumps (NE-500, New Era Pump
Systems Inc., Farmingdale, NY, USA). The pumps were
controlled with software (Python script) developed in-house
(Toft et al., 2008).
2.3. Sample preparation
To test the system, solutions containing lysozyme (buffer:
40 mM NaOAc, 50 mM NaCl, pH 4.0) or glucose isomerase
(buffer: 10 mM HEPES, 1 mM MgCl2, pH 7.0) were continu-
ously pumped into the protein channel on the dialysis chip at a
flow rate of 0.9–1 ml min1. A 100 mg ml1 PEG 20 000 solu-
tion, dissolved in the same buffer as the
protein solution or water, was pumped
in the opposite direction on the PEG
side of the dialysis chip at a flow rate of
10 ml min1. At these flow rates the
deformation of the dialysis channel, due
to increased pressure, is negligible
(Gervais et al., 2006). Before the dialysis
membrane was clamped between the
two PDMS sheets, it was soaked and
rinsed in distilled water for a minimum
of 30 min to rinse out the preservative
(glycerin). The membrane was not
allowed to dry, since this can affect the
pore size.
2.4. UV measurements
Concentration using the dialysis chip
is not linear over time, and UV
absorption at 280 nm monitored imme-
diately prior to the SAXS exposure cell
is thus useful, and in some cases essen-
tial, to determine the concentration of
the protein solution before SAXS
exposure. The concentration of the
sample is important for determining the
average molecular mass of the scatterer
and hence to determine the average
oligomeric state and/or confirming monodispersity during
SAXS data analysis. The UV absorption was monitored using
the UV cell on the exposure chip (see Fig. 1b) following the
same basic principles as given by Lafleur et al. (2011). Optical
fibers with a 250 mm diameter were inserted into the 250 
250 mm side channels on the exposure chip, giving a path
length of 1 mm. The optical fibers were connected to a spec-
trometer and a deep UV source (AvaSpec 2048 and AvaLight-
DH-S-DUV, Avantes Inc Broomfield, CO, USA). Software
(Python script) developed in-house facilitated automated
recording of the absorption at 280 nm as a function of time.
2.5. SAXS experiments
The experiments were carried out on the SAXS stations F2
and G1 at the Cornell High Energy Synchrotron Source
(CHESS). The beam size on both stations was 250  250 mm
(FWHM) at the exposure cell with a flux of 9 
109 photons s1 and an energy of 9.881 keVon F2 and a flux of
3  1011 photons s1 at an energy of 9.869 keV on G1.
Exposure times were limited to 1–2 min on F2 and to 5 s on
the G1 beamline to avoid radiation damage of the samples.
Basic SAXS data processing including radial averaging,
background subtraction and radius of gyration (Rg) estimates
was performed using the open-source data reduction software
RAW (Nielsen et al., 2009).
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Figure 1
Illustration of dialysis and exposure chip design. The setup consists of two microfluidic modules, the
dialysis chip and the exposure chip. (a) The dialysis chip has two identical sides (albeit with varying
channel depth) with channels for the polyethylene glycol and protein sample solution, respectively.
The two sheets are clamped together with a dialysis membrane in between. (b) The outlet of the
dialysis chip sample solution channel is connected to the sample inlet on the exposure chip. The
exposure chip contains a UV cell and a SAXS exposure channel with a polystyrene (PS) window. An
air inlet makes it possible to blow out old sample in the exposure channel and the UV cell.
3. Results
3.1. Reproducibility
UV measurements were used to determine the reproduci-
bility of the concentrations obtained using the dialysis chip in
a continuous flow mode. Three successive experiments were
performed by first filling the dialysis chip with protein sample
and applying a sample flow rate of 1 ml min1 with the PEG
flow rate at 10 ml min1. Each experiment continued for
45 min. Fig. 2(a) shows a slow concentration increase during
the first 10 min, followed by a steeper increase from 20 to
45 min. The reproducibility of protein concentration was
estimated using UV illumination, revealing a maximum stan-
dard deviation of 0.11 mg ml1. Estimated using these data,
the total volume needed to perform a concentration series is
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Figure 2
UV monitoring of protein concentration. (a) Plot of repeated UV-
monitored continuous flow concentration series (n = 3). A lysozyme
solution of 1 mg ml1 was pumped into the sample channel of the dialysis
chip at a flow rate of 1 ml min1. PEG was pumped with the opposite flow
direction into the PEG channel at 10 ml min1. The dialysis chip was
flushed with sample after 45 min at high flow rate and the experiment was
repeated. (b) Running the sample solution at a flow rate of 0.9 ml min1
will result in a fixed concentration after equilibration (in this case just
before the red marking of ‘Flow stopped’ above). Halting the protein
solution flow for a period of time can temporarily result in a higher
protein concentration. In this case the pump was stopped for 7 min.
Figure 3
SAXS-monitored lysozyme concentration series. (a) The scattering
curves obtained during data collection from a concentration series on
lysozyme with an initial concentration of 2.2 mg ml1. Two different
approaches were used. The green scattering curves (light green to dark
green) indicate protein concentration obtained using continuous flow
with a sample flow rate of 1 ml min1 and a PEG flow rate of 10 ml min1.
SAXS data were collected at 5 min intervals. The sample flow was halted
for 10 min. The blue scattering curves show the resulting abrupt
concentration, when the sample flow was reinitiated at 1 ml min1, with
subsequent dilution (light blue to dark blue). SAXS data (blue curves)
were collected with 3 min intervals. The red curve is the scattering curve
from buffer solution. SAXS data were not collected during the stopped
flow. (b) The background-subtracted data. The inset shows the super-
imposed data curves after scaling for concentration.
67 ml. This estimate includes the volume of the dialysis chip
channel (11.15 ml), the dead volume from the end of the
dialysis chip to the X-ray exposure cell (6 ml), the volume of
the X-ray cell (1 ml) and the volume used during a concen-
tration series (45 ml).
3.2. Concentration series
Fig. 2(b) shows a concentration series recorded with UV
absorption at 280 nm, using different flow rates than in
Fig. 2(a). After a typical slow concentration phase, followed by
the steeper increase in concentration, the curve begins to level
out, i.e. resulting in a steady protein concentration. At this
point, the pump injecting sample solution was paused for
7 min. A slight drop in concentration is seen after halting the
pump, followed by a sharp increase in protein concentration
immediately after restarting it. In the present experiment, the
halted flow resulted in a further 150% concentration of the
protein sample.
A SAXS concentration series on lysozyme is shown in
Fig. 3, using a starting concentration of 2.2 mg ml1. The data
reveal the concentration effect by continuous and halted flow.
In both Figs. 3(a) and 3(b) (before and after background
subtraction, respectively) we see a gradual rise in overall
scattering intensity from light-green to dark-green curves,
obtained with 5 min intervals. An approximate factor of three
in concentration was obtained, while a factor of six was
obtained after halting the flow for 10 min. The first measure-
ment after restarting the pump is plotted in light blue, and a
gradual decrease in intensity is observed for the subsequent
measurements (light-blue to dark-blue curves). SAXS data
were not collected during the stopped flow, and a drop in
concentration, as seen in the red box of Fig 2(b), is therefore
not visible in the data.
3.3. Buffer exchange series
Figs. 4 and 5 show data from concentration series where the
PEG has been dissolved in water rather than buffer solution.
Fig. 4 shows the gradually changing scattering curves from
lysozyme at an initial concentration of 1 mg ml1, during
concentration over a period of 80 min. A clear overall increase
is seen in intensity over time (from protein concentration), but
accompanied by the emergence of a downward turn in the
scattering profile at lower q values. This downward trend is a
well characterized signature of long-range interparticle
repulsion in lysozyme solutions, which increases with
decreasing ionic strength (Niebuhr & Koch, 2005; Shukla et al.,
2008; Stradner et al., 2004). A buffer exchange has hence
accompanied the protein concentration procedure. The
change in buffer composition is also apparent at the widest
scattering angles recorded, resulting in a mismatch of the
background subtraction (shown in Fig. 5). This initial experi-
ment hence clearly exposes the need to obtain scattering
measurements also from the modified buffers when collecting
SAXS data during buffer exchange.
3.4. Data quality after protein concentration and buffer
exchange
Fig. 5 illustrates an experiment similar to the lysozyme
concentration and desalting using a glucose isomerase sample
of an initial protein concentration of 3.4 mg ml1. Fig. 5(a)
shows the first and last measurement of a concentration series
and the inset shows the gradual increase in the scattering
signal with time. It is noted that the scattering at medium and
high q values from the buffer measurement for time t = 0 min
is higher than the protein signal from glucose isomerase at t =
43 min, thereby again illustrating the need for the measure-
ment of the correct buffer background, and also revealing the
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Figure 4
SAXS-monitored buffer exchange and concentration series. (a) SAXS
curves from initially 1 mg ml1 lysozyme during concentration and buffer
exchange. The blue scattering curve shows the data for the buffer
solution. (b) Background-subtracted scattering intensity curves. There is
a clear rise in intensity (due to protein concentration) and also a change
in the scattering pattern at low q with increasing time, revealing an
increase in the structure factors and the compromised background
subtraction, owing to the changes in buffer composition over time.
efficiency of buffer exchange across the membrane. An
adequate buffer measurement after buffer exchange is
obtained by running buffer through the sample channel at the
same flow rate as for the protein sample, which hence
produces a buffer measurement that matches the concentrated
sample at t = 43 min. The background-subtracted data are
shown in Fig. 5(b). It is noted that the two background-
subtracted scattering curves are indistinguishable when scaled
for concentration (in this case a factor of 1.7). This proves that
the buffer-exchanged background measurement has been
correctly performed.
After obtaining adequate buffer measurements (hence
applying buffer exchange via dialysis), Rg was estimated for
the scattering curve of the starting concentration (t = 0 min)
and the scattering curve of the final
concentration (t = 43 min) (see Figs. 5c
and 5d). For the starting concentration
(3.4 mg ml1), Rg was estimated as
32.0 A˚ and for the final concentration
(6.5 mg ml1) Rg was estimated as
32.5 A˚. Both estimates are consistent
with what is reported in the literature
[Rg = 32.5 (7) A˚; Mylonas & Svergun,
2007]. It is evident that the concentra-
tion and buffer exchange has not
resulted in any unwanted protein
aggregation and, most importantly, that
the buffer match obtained by dialysis
results in scattering data of adequate
quality.
4. Fluid dynamics and transport
4.1. Theory
The small size scale and relatively
slow flow rates encountered in many
microfluidic applications render simu-
lations of fluid flow well within the
Stokes (creeping) flow regime. The
Reynolds number for a flat channel,
1000 mm wide by 50 mm deep, carrying
water at 1 ml min1 using kinematic
viscosity  = 1.5  106 m2 s1 at 278 K
and assuming a hydrolic diameter of 2
50 mm, is 0.02 << 1. Owing to the
extreme scale difference (20:1)
between width and depth of channels,
we will confine our analysis here to only
two dimensions: channel depth (y) and
channel length (x). Under such condi-
tions, the fluid velocity field u = (ux, uy)
for a simple two-dimensional channel
with one porous wall can be solved
analytically (Appendix A).
Longitudinal flow thus scales linearly
to zero as all the buffer has leaked away
by the time the balance point in the channel is reached. This is
true in both directions. The transverse flow, uy, is completely
independent of x. The flow field is shown in Fig. 6(a) on an
exaggerated scale for illustration, with the membrane being
represented by a dashed line at y = 0. Because of conservation
of volume in this incompressible system, the only flow that
appears is transmembrane flow um. To simulate a finite-length
channel with specified volumetric inlet flow
f ðxÞ ¼ Rd
0
uxðx; yÞ dy ¼ umx; ð1Þ
one simply selects the starting point x to give the desired value
[x = 28 in Fig. 6(a)]. For a channel of length L having an
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Figure 5
SAXS-monitored glucose isomerase (GI) concentration series. (a) Concentration of a glucose
isomerase solution from 3.4 mg ml1 at t = 0 min (shown in purple) to 6.5 mg ml1 at t = 43 min
(shown in black). The two corresponding buffer intensity curves are also plotted, one at t = 0 min
(purple) and one at t = 43 min (black). The required volume was 40 ml from the first to the last
measurement. The sample and the PEG solutions were injected at a rate of 1 ml min1 and SAXS
data were collected every 5 min. The inset shows the gradual concentration of the protein sample.
Buffer changes were induced during concentration in the dialysis chip using PEG in water, rather
than PEG in the protein buffer. (b) Plot of background-subtracted intensity curves at 3.4 mg ml1
(purple) and 6.5 mg ml1 (black) using data from buffers exposed to the same dialysis period as the
protein samples for the background-subtraction procedure. (c) For the starting solution at
3.4 mg ml1, Rg = 32.0 A˚ was determined [qRg(min) = 0.45, qRg(max) = 1.30]. (d) For the final
solution at 6.5 mg ml1 Rg = 32.5 A˚ was determined [qRg(min) = 0.70, qRg(max) = 1.30].
entrance at x = xen, the exit will be located at x = xen  L > 0
[x = 5 in Fig. 6(a)]. Ideally, the concentration factor achieved
as the sample passes from one end to the other would be
f(xen)/f(xen  L) = xen/(xen  L), but Poiseuille flow causes
fluid in the middle of the channel to move more rapidly than
fluid near the membrane surface. Consequently, we can expect
the concentration factor to have some dependency on the
diffusion constant and on the channel dimensions. Under-
standing chip performance thus requires a more detailed
examination of convection and diffusion.
Protein concentration changes within the microfluidic
channel are governed by the convection–diffusion equation:
@c
@t
¼ Dr2c u  rc: ð2Þ
We assume that concentration c(x, y, t) does not affect the
density or the Newtonian flow properties of water. Equation
(2) also assumes that diffusion, D, is constant. A very impor-
tant characteristic of sample behavior near a membrane can
easily be seen by solving the one-dimensional steady-state
version of equation (2) for a finite amount of sample experi-
encing constant transmembrane buffer flow u = (0, um):
@
@y
D
@c
@y
 umc
 
¼ 0: ð3Þ
Simple integration of equation (3) along with the condition of
finite total concentration yields
D
@c
@y
 umc ¼ 0: ð4Þ
which can be solved directly for concentration:
cðyÞ ¼ cð0Þ expðumy=DÞ: ð5Þ
Equation (4) is equivalent to the so-called Robin boundary
condition, but reduces to the more familiar Neumann condi-
tion when um = 0 (Deen, 1998). In the absence of flow
(impermeable, no-leak walls), concentration gradients must
therefore vanish at the walls. However, at permeable walls, the
convective flux combines with diffusion to result in an expo-
nential decay of concentration (recall that um < 0), the width of
which depends upon the diffusion constant of the species
involved. This is a well known and important phenomenon in
field-flow fractionation (Giddings, 1993); massive, slowly
diffusing species concentrate closer to the membrane than
lighter, more rapidly diffusing species. As we shall see in a
moment, this phenomenon has important implications for
chip-based dialysis as well.
The dialysis channel is initially filled with dilute sample: c(x,
y, t) = c0 for xen  L  x  xen and 0  y  d. During
simulation, an inlet boundary condition is imposed to simulate
the constant flow of fresh sample into the channel: c(xen, y) =
c0 for 0 y d. The upper wall y = d is impermeable with ux =
uy = 0. The lower wall, y = 0, also has ux = 0 and experiences a
constant transmembrane buffer flow uy = um but is otherwise
impermeable to solute. The outlet boundary condition at x =
xen  L allows free diffusion and convection outwards.
To solve equation (2) numerically, we utilize the finite
volume method (Versteeg & Malalasekera, 2007) as imple-
mented in the package FiPy (release 3.0; Guyer et al., 2009).
The steady-state form of equation (2) was solved using the
exponential convection term option with equations (12) and
(13) as input. An explicit source term was introduced to
precisely cancel outward diffusion and convection at the
outlet, simulating free flow as described in the FiPy docu-
mentation (http://www.ctcms.nist.gov/fipy/). The simulation
was conducted on a grid of 400 cells (x) by 50 cells (y).
Convergence for steady-state solutions was assessed by
varying the number of cells in the simulation. To assure
accuracy for a wide range of simulation parameters, cell
numbers well in excess of the necessary minimum were
chosen.
The full transient form of equation (2) was solved on the
same grid with the same parameters, but accurate time
propagation required the use of a van Leer convection term
with variable time steps (van Leer, 1979). The necessity of
using this particular strategy in time propagation was seen in
D = 0 test cases where pure translation of sample boluses is
expected. Time steps were started at 0.018 s and doubled every
100 steps to a maximum of 1.152 s per step. In the upstream
end of the tube, high longitudinal flow rates adjacent to very
slow transmembrane flow rates initially require very fine time
stepping, but steady-state conditions are reached very rapidly
in those locations; consequently time steps can be increased
once the steady state is achieved locally. Steady-state flow
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Figure 6
Fluid simulations inside a dialysis chip. (a) Simulated fluid velocity field
inside the chip. Scales and flows are exaggerated for the purpose of
illustration. Vertical lines mark inlet and outlet locations. Fluid velocity is
strictly vertical at the balance point (x = 0), a virtual location normally
outside the chip. The dashed line (y = 0) identifies the membrane surface.
(b) Simulations of steady-state concentration profiles for a rapidly
diffusing lysozyme-like protein (D = 106 cm2 s1). (c) Simulations of
steady-state concentration profiles for a slowly diffusing aggregate (D =
108 cm2 s1). Species slower than D = 5  108 cm2 s1 show a visible
concentration gradient within the 50 mm channel.
conditions progress down the channel with time, reaching the
outlet last. The final states achieved in transient calculations
agreed with those in the steady-state calculations.
4.2. Limitations and approximations
As already mentioned, our simulations treat the wide but
very shallow (20:1) dialysis channels as a two-dimensional
system. Dialysis membranes are known to swell and deform
some in reality, and consequently the true channel depth is not
a precisely known quantity. A more elaborate treatment
would also model the PEG channel as well as the porous
membrane (Tuhy et al., 2012). Further, the microfluidic chan-
nels are not straight but folded to fit on the chip. Such turns in
the channel have a well known distorting influence in micro-
fluidics known as the racetrack effect (Kirby, 2010). Halted-
flow experiments may be further influenced by the so-called
compliance of the device (elastic response to changes in
pressure). Higher concentrations of protein may also intro-
duce interesting non-Newtonian/rheological properties into
the simulation. The formation of so-called polarization layers
is a much-studied phenomenon in ultrafiltration that is closely
related to this work (Song & Elimelech, 1995; Pignon et al.,
2012). Transmembrane flow, which we have assumed constant
in this work, can be impeded in the polarization layer by a
variety of factors when protein solution becomes highly
concentrated. The point of these simulations, however, is not
to model the experimental system in complete detail, but
rather to clarify the essential physics at work and to under-
stand how various design parameters influence the perfor-
mance of the chip.
4.3. Simulation results
The parameters for this simulation were chosen to
approximately model the experimental chip setup (Table 1).
Although outlet flow was not measured directly in these
experiments, the observation that it stopped altogether for
inlet flows less than 0.9 ml min1 gives some approximate
indication of the transmembrane flow rate. At 0.8 ml min1
transmembrane flow, the outlet flow in our simulation gave
both a reasonable refresh time for exposed sample in the
X-ray beam and a steady-state concentration factor close to
that actually observed in Fig. 2(b) during the first 60 min of
operation. To move sample from the end of the channel to the
X-ray cell, a dead volume of 6 ml, required nearly 27 min
(Table 1), and consequently the simulations of time to reach
steady state are most meaningfully compared with the range
from 30 to 60 min in Fig. 2(b). Stopped flow is not modeled in
these simulations.
Figs. 6(b) and 6(c) show examples of the steady-state
concentration gradient within the channel for proteins of two
very different diffusion constants. In Fig. 6(b), a rapidly
diffusing protein such as lysozyme (D ’ 106 cm2 s1) fills the
narrow 50 mm channel near the outlet. A much more slowly
diffusing protein or aggregate (D ’ 108 cm2 s1) shows a
distinct concentration gradient, which is highest near the
membrane surface (Fig. 6c). The color bar on the right-hand
side of Fig. 6 gives an indication of concentration range.
The full transient form of equation (9) is solved in Fig. 7 for
a range of diffusion constants from 106 cm2 s1 down to
109 cm2 s1. AboveD = 5 108 cm2 s1, all curves show the
same behavior, in which the steady state with idealized
concentration factor of 4.5 is reached in 20 min (Fig. 7a).
Below D = 5  108 cm2 s1, samples take progressively
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Table 1
Simulation parameters.
Flow at inlet (ml min1) 1.02
Flow at outlet (ml min1) 0.23
Transmembrane flow (um) (ml min
1) 0.80 (0.0215 cm h1)
Inlet to balance point (cm) 28.6
Channel dimensions (cm) 23.3  0.1  0.005
Idealized concentration factor 4.5
Time for X-ray cell refresh (min) 2.21 (0.5 ml)
Time from outlet to X-ray cell (min) 26.58 (6.0 ml)
Figure 7
Theoretical chip performance with various types of proteins. Number
labels are diffusion constants in cm2 s1. (a) Time to reach steady state is
20 min (effect of dead volume not shown) for fast-diffusing proteins. Slow
proteins and aggregates take more than 30 min but are more
concentrated when they reach the outlet. (b) Steady-state concentration
gradient at outlet. For proteins faster than a certain threshold (8.5 
108 cm2 s1), the profile is flat and the final concentration and
equilibration time are independent of diffusion. Slow proteins or
aggregates are diffusion-limited and concentrate in the slow-moving flow
near the membrane surface. As such, they take much longer to elute but
ultimately reach a higher concentration.
longer to reach the steady state, but when they do, the final
concentration factor is higher. Fig. 7(b) reveals that cross-
sectional concentration gradients near the outlet go from flat
to exponential as they cross the D = 5  108 cm2 s1
threshold. Large proteins or aggregates thus show diffusion-
limited behavior in the chip, leading to higher concentrations
in slower parts of the flow field. As a result, the larger the
protein, the more delayed the arrival. All sample components
above a certain threshold diffusion rate will arrive at the outlet
at the same time and be concentrated to the same extent (so
long as the channel is much longer than the characteristic
diffusion time).
5. Discussion
In order to adequately benefit from SAXS beamtime at the
large scale facilities, and to optimize the spending of precious
macromolecular samples, it is highly desirable to develop
advanced sample handling devices. The microfluidic device
presented here requires minimal sample handling and enables
‘on-the-fly’ protein concentration and buffer exchange. The
design presented here combines a UV absorption cell and a
SAXS measurement cell in an exposure chip module separate
from a simple dialysis module. This proof of concept setup
shows how structural changes and small changes in the
experimental conditions are readily monitored using UV and
SAXS.
Microfluidic devices for enrichment of protein solutions
have previously been reported (Khandurina et al., 2000; Wang
et al., 2005; Kim & Han, 2008; Kondapalli et al., 2011), but
these devices demand either very complex fabrication tech-
niques or the use of electric field flow. The presented micro-
fluidic chips can be treated as disposables because of the low
costs of PDMS and fast production, as reported earlier (Kim et
al., 2007). Furthermore, the combination of an automated
microfluidic device and associated partially automated soft-
ware provides the user with structural feedback immediately
during data collection, exposing potential structural changes
caused by the experimental changes in the sample. The ease of
adjustment of the experimental conditions in the microfluidic
setup provides the user with the flexibility to respond to and
optimize data collection during beamtime.
5.1. Flowrate/exposure times and radiation damage
The dialysis chip enables SAXS experiments conducted
from protein samples of initially low concentrations that are
then gradually enriched via a gentle dialysis approach.
By starting with dilute protein and working upward in
concentration while performing SAXS measurements, poten-
tial structural changes are monitored and the initial formation
of possibly irreversible aggregation is readily detected. By this
principle, it is ensured that a SAXS measurement is performed
at the highest possible protein concentration devoid of
unwanted effects such as aggregation and structure factor
distortions. Aggregation can also be a time-dependent
phenomenon. The ability to perform ‘on-the-fly’ measurement
is an absolute advantage, rather than first concentrating (off-
line) and then transporting the sample to the beamline for
measurements. Such concentration series are also expected to
be valuable in the analysis of concentration-dependent
oligomerization or molecular crowding effects, where the
maximally achievable concentration is unknown.
Owing to the minute amounts of sample that are consumed
on the dialysis chip, fast sample movement is not possible
during exposures. This makes the sample sensitive to radiation
damage and sets a practical limit for the exposure time. The
practical exposure limit is dependent on the intensity of the
X-ray beam at the beamline. It is also possible to vary the
actual X-ray dosage on the sample by modifying the focus and
therefore the size of the X-ray beam at the sample position. In
the present experiments, protein aggregation was not detected
and hence radiation-induced aggregation has not been a
problem. By using pixel array detectors, very low timeframes
of sample exposure may be used, thereby enabling direct
monitoring of potential X-ray-induced sample damage.
5.2. Concentration series
Concentration of protein solution was achieved using both
continuous flow and halted (stopped) flow. A factor of three–
four in concentration was achieved with continuous flow. The
maximum concentration was achieved using a combination of
continuous flow and halted flow where a factor of six in
concentration was reached. Initially, the concentration
remains flat until 6 ml of dead volume is expelled. A
maximum in concentration (the steady state) is seen when the
slope of the curve starts to decrease. However, halting the flow
at this point and waiting several minutes caused a temporary
increase of the concentration. In effect, the balance point of
the device resided inside the chip for that time. Once flow
resumes, a bolus of higher concentration is expelled, creating a
new temporary plateau. The small decrease in concentration
right after the stopping of the pump is likely to be due to
dilution by previously measured sample in the UV exposure
cell.
In an attempt to obtain the maximum protein concentra-
tion, the protein solution flow rate was kept at the lowest
possible, but still allowing the protein solution to propagate
towards the exposure cell with enough sample volume in a
reasonable timeframe, i.e. close to the rate of solute transport
across the dialysis membrane. For the parameters used in
these studies, the optimized flow rate was found to be around
1 ml min1. At flow rates below 0.9 ml min1 the sample flow
rate is exceeded by the rate of buffer transportation through
the membrane, resulting in no or reversed propagation of the
sample in the protein channels.
5.3. Desalting of protein solution and background subtrac-
tion
The dialysis chip also facilitates the study of structural
changes due to gradual changing of buffer components such as
removal or addition of ions from the sample solution. It is
important to note that the change of buffer conditions in a
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sample will also require the exact same changes to the buffer
used for background subtraction when using SAXS. Here, we
have shown that this can be obtained by exposing the buffer
samples to the same microfluidic handling as for the protein
solution.
Fig. 4 shows an example of gradual concentration and
desalting of lysozyme. The results indicate a clear change in
the lower-q area of the scattering curve, as would be expected
from desalting because of the increasing structure factor
effects (Shukla et al., 2008). It should be emphasized, however,
that these structure factor changes are not monitored in detail,
owing to the noted compromise in background subtraction
when using the initial buffer measurement for this procedure
only.
In contrast, we demonstrate (Fig. 5) how running the buffer
through the chip while using the same flow rate as for the
sample provides a buffer measurement that matches the
sample measurement at a specific time (t). The data also
clearly illustrate how reproducible scattering profiles can be
extracted from glucose isomerase even after both concentra-
tion and buffer changes. This indicates that the protein did not
experience damage (forming aggregates) either from the
induced concentration and buffer exchange or from X-ray
exposure. Additionally, and perhaps more importantly, the
results demonstrate the reproducibility of dialysis, since we
obtain a perfect background match from the buffer
measurement on the same dialysis chip. However, it must be
noted that this procedure doubles the demand in beamtime.
5.4. Dialysis, ultrafiltration and pressure balance
Differences in osmotic pressure between the sample and the
PEG solution drive the flow of buffer across the semiperme-
able membrane. PEG 20 000 provides a significant pressure
differential of 152 kPa at 100 mg ml1 (Williams & Shaykewi,
1969), but PEG is also a very viscous fluid that can build up a
significant pressure simply flowing through a channel. Internal
channel pressure works in opposition to osmotic pressure in
this case, potentially lowering the effective concentrating
ability. Sufficient opposing pressure could, in fact, reverse the
buffer flow (ultrafiltration). The resulting pressure gradient
along the length of the channel could also introduce non-
linearities in performance. The Hagen–Poiseuille formula,
which relates pressure drop through a channel with flow rate
and viscosity, has recently been modified to account for
rectangular cross-sectional channels (Biral, 2012). Let Q be
flow rate, L be channel length, and w and h be width and
height, respectively (SI units). If  is the dynamic viscosity
(Pa s), then
p ¼ 12LQ
wh3

1 192h
5w
tanh

w
2h
1
: ð6Þ
For PEG 20 000 at 10% w/w,  = 0.01 Pa s, an order of
magnitude larger than water (Holyst et al., 2009). Conve-
niently, the density of PEG 20 000 is quite close to unity. At
Q = 10.0 ml min1, the predicted pressure differential for PEG
flow in the 0.12 1.0 220 mm channel is thus 2.8 kPa, about
2% of the osmotic pressure. The effect is insignificant in this
experiment and can be ignored, but could easily become a
factor of importance with longer narrower channels or higher
PEG flow rates.
The range of possible osmotic pressures of protein solution
relative to buffer is estimated using the simple Morse equation
(Foley, 2013). For lysozyme (14.3 kDa at 1–6 mg ml1) osmotic
pressures are estimated to range from 0.2 to 1 kPa, consistent
with published values measured under higher salt conditions
(Moon et al., 2000). Glucose isomerase (173 kDa) in the same
range of concentrations yields even lower pressures (0.014–
0.084 kPa). From the standpoint of dialysis, PEG solutions far
exceed the necessary osmotic pressure difference to cause
concentration. However, when expressed in units of mm H2O
(10 Pa ’ 1 mm H2O), it becomes evident that protein
concentration and buffer exchange could be accomplished
without PEG through the use of external pressure alone.
Indeed, ultrafiltration has already been combined with SAXS
measurements to probe the polarization layers in colloidal
dispersions and micelles (David et al., 2008; Pignon et al.,
2012). The extent to which behavior in those regimes applies
to typical protein solutions should be a fruitful area for future
investigation.
5.5. Fluid dynamics, transport and retention of aggregates
Whether flow through the membrane is induced by osmotic
pressure or external pressure, it has important hydrodynamic
effects on proteins in the channel. FFF experiments have
already demonstrated that species with different mass are
naturally separated under these conditions (Giddings, 1993).
In the AF4 method, samples flow along a single very wide
(>1 cm) but shallow (<500 mm) channel defined on one side by
a semipermeable membrane that admits only buffer. The
transverse flow of buffer through the membrane combines
with parabolic (Hagen–Poiseuille) flow tangent to the
membrane to separate species with differing rates of diffusion.
Though the channels in our dialysis chip are much narrower
than typical AF4 configurations, the depth and flow para-
meters are comparable. Analysis of convection and diffusion
phenomena within the chip shows that mass separation can
indeed occur, and that larger particles such as aggregates will
be significantly retarded. The present design, however, does
not provide mass resolution for species with diffusion
constants aboveD = 5 108 cm2 s1. Most common proteins
in their native oligomeric state will not be resolvable from
their dimeric or tetrameric forms in this case. The choice of
channel depth (50 mm here) is the most important design
parameter influencing mass resolution. Future designs may be
able to offer a greater degree of incidental sample purification.
6. Conclusion
A microfluidic setup for remote-controlled and ‘on-the-fly’
dialysis and buffer exchange in combination with SAXS is
presented. This proof of concept demonstrates how micro-
fluidic dialysis, coupled with a SAXS/UVexposure cell, can be
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used for concentration-scanning series and for dynamically
monitoring structural changes in response to changing buffer
conditions. Rather than having to handle minute volumes of
concentrated samples, the microfluidic dialysis starts with
large volumes of dilute solution; this facilitates handling and
reduces potential loss. The concentration factors (4 to 6)
achieved in these preliminary experiments are promising and
adequate for checking sample concentration dependence. On-
chip UV absorption measurement permits real-time determi-
nation of sample concentration during the experiment, a
necessary requirement for mass estimation. In buffer
exchange experiments, a well matched buffer can be achieved
by running a duplicate experiment with buffer instead of
sample.
Because the sample may become highly concentrated near
the dialysis membrane, a valid concern is whether or not the
concentration process can induce aggregation. None has been
observed at the levels of concentration achieved in these
experiments. Further, detailed transport calculations strongly
suggest that any aggregates that might be produced will be
detained on the microfluidic chip. Thus, microfluidic dialysis
may accomplish some sample purification as an unexpected
side benefit.
The design presented here is readily implemented on a
SAXS beamline. Easily changeable, low-cost membranes and
disposable sample chips are compatible with a high-
throughput environment. The high level of automation of the
fluid control, data acquisition and initial data analysis allows
the user to concentrate on the experimental design and initial
conclusions, and hence promises an optimized use of often
very precious protein samples. All software is freely available
upon request.
APPENDIX A
Under the assumption of viscous flow, the Navier–Stokes
equations reduce to
rp ¼ r2u; ð7Þ
where p is pressure,  is dynamic viscosity and u = (ux, uy) is
the vector field describing flow (Kirby, 2010). Introducing a
scalar function (x, y) and using the transformation
ux ¼
@
@y
; uy ¼ 
@
@x
; ð8Þ
pressure and viscosity drop out of the equation and one
obtains the fourth-order two-dimensional biharmonic equa-
tion (Kirby, 2010)
r4 ¼ @
4
@x4
þ @
4
@y4
þ 2 @
4
@x2@y2
¼ 0: ð9Þ
For an infinite channel of depth d having one semipermeable
side with outward flow um, we can impose no-slip boundary
conditions at the walls: ux(x, 0) = ux(x, d) = 0. Further, there is
no leakage at the top wall, uy(x, d) = 0, and specified leakage at
the bottom wall, uy(x, 0) = um. Note that for concentration to
occur in the chip, um is less than 0. We can further expect
sample solution traveling in the positive x direction to even-
tually come to a stop as the net flow down the tube becomes
equal to the net flow out of the membrane. For symmetry, we
can assume that buffer solution is travelling in the negative x
direction to meet up with the sample at x = 0. We refer to this
location as the balance point. Generally, the balance point is a
virtual location somewhere outside the dialysis chip down-
stream from the outlet. So at the stationary line x = 0 we have
ux(0, y) = 0 for both fluids. This symmetry actually places much
stronger requirements on the solution of the equation. We can
say that ux(x, y) = ux(x, y) and uy(x, y) = uy(x, y). So ux is
an odd function and uy is an even function. To understand how
to apply these boundary conditions, it is necessary to expand
the solution in terms of elementary functions with coefficients.
Fortunately, one can accomplish this with a simple polynomial
expansion:
ðx; yÞ ¼P3
i¼0
P3
j¼0
ai;jx
iyj: ð10Þ
Using transformation (8), we can impose the boundary
conditions above. Since ux is odd in x, a0,1 = a0,2 = a0,3 = 0.
Similarly, since uy is even in y, a2,0 = a2,1 = a2,2 = a2,3 = 0. No-slip
conditions at both walls results in a1,1 = a3,1 = 0, a1,2 =3/2a1,3d
and a3,2 =3/2a3,3d. Similarly, no-leak conditions yield a1,0 = 1/
2a1,3d
3. Specified-leak conditions are only satisfied if a3,3 = 0
and a1,3 = 2um/d3. Substituting these coefficients into equa-
tion (10), we obtain
 ¼ um
d3
x
 d3 þ 3dy2  2y3; ð11Þ
@
@y
¼ ux ¼
6um
d3
xyðd yÞ ð12Þ
and
 @
@x
¼ uy ¼
um
d3

d3  3dy2 þ 2y3: ð13Þ
It is easy to verify that the stream function  obeys equation
(9). The longitudinal fluid velocity ux [equation (12)] is
recognizable as the famous Poiseuille flow pattern, but
modulated by a factor of x. Curiously, the two-dimensional
flow field for a more symmetric channel having two porous
walls has been solved, though apparently not in a simple
closed analytic form such as we have presented here, but one
requiring perturbation methods (Berman, 1953).
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